Safety vs Price in the Generic Drug Market: Metformin

The generic drug market focuses on price. However, multiple generic metformin drugs have been recalled due to poor drug quality. We examine price and quality after these recalls.

Related Keywords

Nigeria ,South Korea ,New York ,United States , Ekadashi ,Benue ,Lagos State ,Lagos ,Han ,Ann Pharmacother ,Kevina Schulman ,Mary Denigan Macauley ,Pharm Weinheim ,Red Oak Sourcing ,Lupin Pharmaceuticals Inc ,Testimony Before The Committee On ,International Agency For Research On Cancer ,Drug Administration ,School Of Medicine ,Rural Development ,Stanford University ,School Of Business ,Health Aff Millwood ,Scripts Inc ,Committee For Medicinal Products Human ,Clinical Excellence Research Center ,New York Times ,Antagonists Sartans Containinga Tetrazole Group ,Amneal Pharmaceuticals ,Us Government Accountability Office ,National Drug Code ,Pfizer Inc ,Stanford University Medicine ,Apotex Inc ,European Medicines Agency ,Clarusone Sourcing Services ,Committee On Energy ,Pfizer ,International Organization For Standardization ,Scandj Work Environ Health ,Teva Pharmaceuticals United States Inc ,Marksans Pharma Ltd ,Foreign Inspection Program ,Health Care ,Viona Pharmaceuticals Inc ,Stanford Health Care ,Intj Environ Res Public Health ,Amneal Pharmaceuticals Inc ,Foreign Drug Inspection Program ,Zhengq Development ,Health Affairs Forefront ,Mckesson Corp ,World Health Organization ,Committee On Appropriations ,Association For Accessible Medicines ,Oak Sourcing ,Express Scripts Inc ,International Organization ,Generic Metformin ,Medicaid State Drug Utilization Data ,Lupin Pharmaceuticals ,Teva Pharmaceuticals United States ,Appendix Table ,Drug Price Competition ,Patent Term Restoration Act ,Hatch Waxman Act ,Accountability Office ,International Agency ,Medicaid State Drug Utilization ,New Haven ,Graduate School ,Civica Rx Scientific Advisory ,Palo Alto ,Nitrosamine Impurities ,Human Drugs ,Drug Evaluation ,Pharmaceuticals Inc ,Pharm Biomed ,Food Drug ,Rev Anal ,Medicinal Products ,Assessment Report ,Receptor Antagonists ,Already Challenged ,Inspection Program ,Testimony Before ,Accessed October ,Inspection Plans Need ,Address Issues Presented ,Testimony Before Subcommittee ,Related Agencies ,Findings Indicate Persistent Challenges With ,Accessed January ,Data Management ,More Inspections Are Needed ,Government Accountability Office ,Arch Pharm ,Limit Potential Carcinogenic Risk ,Biologics Evaluation ,Pharm Sin ,Biosimilars Access ,Accessible Medicines ,Scandj Work Environ ,Metformin ,Fda ,Recall ,Safety ,Generic ,Price ,